Cargando…
Development of a palivizumab specialty pharmacy management program
Background: Palivizumab is indicated for the prevention of serious lower respiratory tract disease caused by respiratory syncytial virus (RSV) in high risk pediatric patients. Due to the high cost, handling requirements, administration route, and importance of adherence, palivizumab is best managed...
Autores principales: | Harlan, Lana, Benskin, Katlyn, Gatzke, Carolin, Majors, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6764365/ http://dx.doi.org/10.1080/21556660.2019.1658299 |
Ejemplares similares
-
Management of specialty drugs, specialty pharmacies and biosimilars in the United States
por: Brook, Richard A., et al.
Publicado: (2019) -
Evaluation of a specialty pharmacy health coaching program
por: Simonson, Dana, et al.
Publicado: (2019) -
Arthroscopic Management of Pigmented Villonodular Synovitis of the Hip in Children and Adolescents
por: Willimon, S. Clifton, et al.
Publicado: (2018) -
Development of a specialty pharmacy productivity benchmarking model
por: Platt, Thom, et al.
Publicado: (2019) -
Feasibility of a Randomized Clinical Trial for Treatment of Femoroacetabular Impingement of the Hip
por: Boye, Gloria N., et al.
Publicado: (2015)